Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181641 | SCV000233944 | uncertain significance | not provided | 2014-05-16 | criteria provided, single submitter | clinical testing | p.Gly77Arg (GGA>AGA) c.229 G>A (NM_000138.4) The G77R variant has not been published as a mutation or as a benign polymorphism to our knowledge. The G77R variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In addition, the G77R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is completely conserved across species. In silico analysis predicts this variant is possibly damaging to the protein structure/function. Furthermore, missense mutations in nearby residues (W71R, C80Y, C80G, C80R) have been reported in association with Marfan syndrome, supporting the functional importance of this region of the protein.Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in TAAD panel(s). |
Invitae | RCV000812218 | SCV000952525 | likely pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 77 of the FBN1 protein (p.Gly77Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Marfan syndrome (PMID: 32939518; Invitae). ClinVar contains an entry for this variant (Variation ID: 200140). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FBN1 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Ambry Genetics | RCV002444730 | SCV002734837 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-12-07 | criteria provided, single submitter | clinical testing | The p.G77R variant (also known as c.229G>A), located in coding exon 2 of the FBN1 gene, results from a G to A substitution at nucleotide position 229. The glycine at codon 77 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been reported in a subject with features of Marfan syndrome (Yalcintepe S et al. Glob Med Genet, 2020 Aug;7:68-71). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genetics and Molecular Pathology, |
RCV002466462 | SCV002761859 | likely pathogenic | Marfan syndrome | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485197 | SCV002778834 | uncertain significance | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-11-08 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001535800 | SCV001749970 | not provided | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Familial thoracic aortic aneurysm and aortic dissection | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 11-16-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |